Evidencefor the decisions ahead

Statistical and regulatory support for pharmaceutical and biotech teams, from early development through to submission and beyond.

Discuss a project
Two scientists in a laboratory, reviewing analytical output on a monitor

Sound analysis. Practical insight.Real-world impact for complex development and regulatory decisions.

Quality

Robust methods, careful review and documentation appropriate to regulated work.

Rigour

Experienced statistical judgement applied to complex development questions.

Trust

Direct senior involvement, clear communication and dependable delivery.

Our Services

View all services
01

Clinical Biostatistics

Study design, analysis and reporting across clinical development, from early phase through submissions.

Learn more
02

CMC Statistics

Statistical support for process development, characterisation, validation, stability and lifecycle work.

Learn more
03

Regulatory Analytics

Analysis and evidence support for submissions, regulatory questions and lifecycle changes.

Learn more
04

Data & Product Engineering

Data systems, analytics and tools to support regulated decision making at scale.

Learn more

Swipe for more

Global biotech · Phase II oncology

Reworking a primary endpoint strategy ahead of Phase III

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Context
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Question
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Approach
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Outcome
Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Primary endpoint

Mean response over time

Real-world evidence.
Measurable progress.

Our Leadership

Senior expertise at every stage of development.

EndPointScience is a specialist statistical consultancy founded by biostatistician Halima Boutouil. Specialising in [verified disciplines], the practice supports pharmaceutical and biotech teams across [verified areas/stages]. Clients work directly with senior specialists throughout each engagement, from planning and analysis through to reporting, submission support and lifecycle work.

Founder portrait, placeholder image

Our focus is simple: to provide clear, rigorous and practical statistical and regulatory support that helps our clients bring important therapies to patients.

Halima BoutouilFounder, EndPointScience

Selected clients

  • Asterion
    Therapeutics
  • Northstar
    Biologics
  • Vela
    Pharma
  • Meridian
    Life Sciences
  • Orchard
    Therapeutics
  • Pioneer
    Bio